---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-062105"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:51:39.830503+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Orchestra BioMed stockholders elect directors, ratify auditor at 2025 annual meeting

## Summary
- Class II directors Chris Cleary, Pamela Connealy, David Pacitti elected to serve until 2028.
- Ernst & Young LLP ratified as independent auditor for fiscal year ending Dec. 31, 2025.
- 28,177,159 of 38,312,512 eligible shares represented at the June 24, 2025 annual meeting.
- Each director received over 24.5 million votes for and ~3.6 million broker non-votes.
- Auditor ratification passed with 28,140,709 votes for, 34,087 against, 2,363 abstentions.

## SEC filing metadata
- accession: 0001104659-25-062105
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000110465925062105/0001104659-25-062105-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000110465925062105/tm2518830d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-062105
- JSON: https://secwatch.observer/filing/0001104659-25-062105.json
- Plain text: https://secwatch.observer/filing/0001104659-25-062105.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.